Impact of COVID-19 on Acute Myocardial Infarction Care.
Autor: | Guddeti RR; Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA., Yildiz M; The Christ Hospital Health Network, 2139 Auburn Avenue Suite 424, Cincinnati, OH 45219, USA., Nayak KR; Scripps Mercy Hospital, San Diego, CA 92103, USA., Alraies MC; DMC Harper University Hospital, Detroit, MI 48201, USA., Davidson L; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Henry TD; The Christ Hospital Health Network, 2139 Auburn Avenue Suite 424, Cincinnati, OH 45219, USA., Garcia S; The Christ Hospital Health Network, 2139 Auburn Avenue Suite 424, Cincinnati, OH 45219, USA. Electronic address: santiagogarcia@me.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Heart failure clinics [Heart Fail Clin] 2023 Apr; Vol. 19 (2), pp. 221-229. |
DOI: | 10.1016/j.hfc.2022.08.004 |
Abstrakt: | The global health crisis caused by the COVID-19 pandemic has evolved rapidly to overburden health care organizations around the world and has resulted in significant morbidity and mortality. Many countries have reported a substantial and rapid reduction in hospital admissions for acute coronary syndromes and percutaneous coronary intervention. The reasons for such abrupt changes in health care delivery are multifactorial and include lockdowns, reduction in outpatient services, reluctance to seek medical attention for fear of contracting the virus, and restrictive visitation policies adopted during the pandemic. This review discusses the impact of COVID-19 on important aspects of acute MI care. Competing Interests: Disclosure Dr S. Garcia is a consultant for Medtronic, Edwards Lifesciences, BSCI, and Abbott Vascular; has received institutional research grants from Edwards Lifesciences, Abbott Vascular, Gore, and BSCI; and is a proctor for Edwards Lifesciences. The other authors have nothing to disclose. (Copyright © 2022 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |